BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    INDUCTOS

    MDR report key: 21749303 · Received April 2, 2025

    Report

    Report Number
    1030489-2025-01596
    Event Type
    Malfunction
    Date Received
    April 2, 2025
    Date of Event
    March 7, 2025
    Report Date
    March 27, 2026
    Manufacturer
    MEDTRONIC SOFAMOR DANEK USA, INC.
    Product Code
    NEK
    PMA / PMN Number
    SEE H11
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    FR
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

    Additional Manufacturer Narrative · 0

    G4 510(K)#: THIS PART IS NOT APPROVED FOR USE IN THE UNITED STATES; HOWEVER A LIKE DEVICE CATALOG # 7510800, PMA # P000058 AND UDI # (B)(4) WAS CLEARED IN THE UNITED STATES. H6: NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

    Description of Event or Problem · 0

    ADDITIONAL INFORMATION RECEIVED FROM MANUFACTURER REPRESENTATIVE THAT IN THE FIRST INTERVENTION IT WAS USE OF FRAGMENTED CANCELLOUS ALLOGRAFT IN ADDITION TO AN AUTOGRAFT (GROUND BONE MIXTURE) BUT IT HAPPENED A PSEUDARTHROSIS OF THE TIBIA. INDUCTOS WAS USED IN THE ADDITIONAL SURGERY AND INDUCTOS DID NOT CAUSETHE ADDITIONAL SURGERY. OFF LABEL USE RELATED TO OSTEOSYNTHESIS BY PLATE. AND THE FUSION IS FULLY CONSOLIDATED.

    Description of Event or Problem · 0

    INFORMATION WAS RECEIVED FROM HEALTHCARE PROVIDER (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT HAVING SPINAL THERAPY FOR PSEUDARTHROSIS OF THE TIBIA. IT WAS REPORTED THAT THERE WAS REVISION SURGERY OCCURRED. THERE WERE NO FURTHER SYMPTOMS REPORTED REGARDING THE EVENT. ADDITIONAL INFORMATION RECEIVED FROM MANUFACTURER REPRESENTATIVE THAT IN THE FIRST INTERVENTION IT WAS USE OF FRAGMENTED CANCELLOUS ALLOGRAFT IN ADDITION TO AN AUTOGRAFT (GROUND BONE MIXTURE) BUT IT HAPPENED A PSEUDARTHROSIS OF THE TIBIA. INDUCTOS WAS USED IN THE ADDITIONAL SURGERY AND INDUCTOS DID NOT CAUSETHE ADDITIONAL SURGERY. OFF LABEL USE RELATED TO OSTEOSYNTHESIS BY PLATE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2699378 INDUCTOS FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC P NEK MEDTRONIC SOFAMOR DANEK USA, INC. 751090001 UNKNOWN

    Patients

    Seq Age Sex Outcome Treatment
    1 26 YR Male